109 related articles for article (PubMed ID: 8769407)
1. Somatostatin analogs in ectopic corticotropin production.
von Werder K; Muller OA; Stalla GK
Metabolism; 1996 Aug; 45(8 Suppl 1):129-31. PubMed ID: 8769407
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for somatostatin and its analogs in Cushing's syndrome?
de Herder WW; Lamberts SW
Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
de Herder WW; Krenning EP; Malchoff CD; Hofland LJ; Reubi JC; Kwekkeboom DJ; Oei HY; Pols HA; Bruining HA; Nobels FR
Am J Med; 1994 Apr; 96(4):305-12. PubMed ID: 8166148
[TBL] [Abstract][Full Text] [Related]
4. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
5. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma.
Rieu M; Rosilio M; Richard A; Vannetzel JM; Kuhn JM
Horm Res; 1993; 39(5-6):207-12. PubMed ID: 8314205
[TBL] [Abstract][Full Text] [Related]
7. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide.
Van den Bruel A; Bex M; Van Dorpe J; Heyns W; Bouillon R
Clin Endocrinol (Oxf); 1998 Oct; 49(4):541-6. PubMed ID: 9876354
[TBL] [Abstract][Full Text] [Related]
8. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.
Lamberts SW; Hofland LJ; de Herder WW; Kwekkeboom DJ; Reubi JC; Krenning EP
Front Neuroendocrinol; 1993 Jan; 14(1):27-55. PubMed ID: 8097480
[TBL] [Abstract][Full Text] [Related]
9. Octreotide and ectopic Cushing's syndrome--a commentary.
James RA
Clin Endocrinol (Oxf); 1998 Oct; 49(4):419-20. PubMed ID: 9876337
[No Abstract] [Full Text] [Related]
10. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide.
Bertagna X; Favrod-Coune C; Escourolle H; Beuzeboc P; Christoforov B; Girard F; Luton JP
J Clin Endocrinol Metab; 1989 May; 68(5):988-91. PubMed ID: 2565915
[TBL] [Abstract][Full Text] [Related]
12. Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?
Uwaifo GI; Koch CA; Hirshberg B; Chen CC; Hartzband P; Nieman LK; Pacak K
J Endocrinol Invest; 2003 Aug; 26(8):710-7. PubMed ID: 14669823
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.
De Rosa G; Testa A; Liberale I; Pirronti T; Granone P; Picciocchi A
Exp Clin Endocrinol; 1993; 101(5):319-25. PubMed ID: 8299710
[TBL] [Abstract][Full Text] [Related]
14. Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients.
Torpy DJ; Chen CC; Mullen N; Doppman JL; Carrasquillo JA; Chrousos GP; Nieman LK
J Clin Endocrinol Metab; 1999 Apr; 84(4):1186-92. PubMed ID: 10199751
[TBL] [Abstract][Full Text] [Related]
15. The role of somatostatin analogs in Cushing's disease.
van der Hoek J; Lamberts SW; Hofland LJ
Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.
Woodhouse NJ; Dagogo-Jack S; Ahmed M; Judzewitsch R
Am J Med; 1993 Sep; 95(3):305-8. PubMed ID: 8396322
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
[TBL] [Abstract][Full Text] [Related]
18. The Ectopic Adrenocorticotropic Hormone Syndrome: Rarely Easy, Always Challenging.
Hayes AR; Grossman AB
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):409-425. PubMed ID: 29754641
[TBL] [Abstract][Full Text] [Related]
19. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor.
Christin-Maitre S; Chabbert-Buffet N; Mure A; Boukhris R; Bouchard P
Chest; 1996 Mar; 109(3):845-6. PubMed ID: 8617102
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
Phlipponneau M; Nocaudie M; Epelbaum J; De Keyzer Y; Lalau JD; Marchandise X; Bertagna X
J Clin Endocrinol Metab; 1994 Jan; 78(1):20-4. PubMed ID: 7904613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
